Vasodilating dipeptide Trp-His can prevent atherosclerosis in apo E-deficient mice

British Journal of Nutrition

Volumn 103, Issue 3, 2010, Pages 309-313

  Matsui, Toshiro ^a   Sato, Masao ^a   Tanaka, Mitsuru ^a   Yamada, Yasuna ^a   Watanabe, Shimpei ^a   Fujimoto, Yumiko ^a   Imaizumi, Katsumi ^a   Matsumoto, Kiyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Dipeptides; Hypertension; Vasodilation

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRYPTOPHYLHISTIDINE; UNCLASSIFIED DRUG; VASODILATOR AGENT; DIPEPTIDE; OLIGOPEPTIDE; TRYPTOPHYL HISTIDINE; TRYPTOPHYL-HISTIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; FOOD INTAKE; LIPID DIET; MALE; MOUSE; NONHUMAN; ANIMAL; AORTA SINUS; BLOOD; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; MUS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, HDL; DIPEPTIDES; LIPIDS; LIVER; MALE; MICE; MICE, KNOCKOUT; OLIGOPEPTIDES; SINUS OF VALSALVA; VASODILATOR AGENTS;

EID: 77449108041     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509991814     Document Type: Article

References (31)

1. Kawasaki T, Seki E, Osajima K, et al. (2000) Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J Hum Hypertens 14, 519-523.
2. Hata Y, Yamamoto M, Ohni M, et al. (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64, 767-771.
3. Matsufuji H, Matsui T, Ohshige S, et al. (1995) Antihyperten-sive effects of angiotensin fragments in SHR. Biosci Biotechnol Biochem 59, 1398-1401.
4. Matsui T, Hayashi A, Tamaya K, et al. (2003) Depressor effect induced by dipeptide, Val-Tyr, in hypertensive transgenic mice is due, in part, to the suppression of human circulating renin-angiotensin system. Clin Exp Pharm Phys 30, 262-265.
5. 2\+ channel inhibition in cultured vascular smooth muscle cells. Hypertens Res 28, 545-552.
6. Tanaka M, Matsui T, Ushida Y, et al. (2006) Vasodilating effect of di-peptides in thoracic aortas from spontaneously hypertensive rats. Biosci Biotechnol Biochem 70, 2292-2295.
7. Tanaka M, Tokuyasu M, Matsui T, et al. (2008) Endothelium-independent vasodilation effect of di-and tri-peptides in thoracic aorta of Sprague-Dawley rats. Life Sci 82, 869-875.
8. Masuda O, Nakamura Y & Takano T (1996) Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 126, 3063-3068.
9. Erdmann K, Grosser N, Schipporeit K, et al. (2006) The ACE inhibitory dipeptide Met-Tyr diminished free radical formation in human endothelial cells via induction of heme oxygenase-1 and ferritin. J Nutr 136, 2148-2152.
10. Navab M, Anantharamaiah GM, Reddy ST, et al. (2005) Oral small peptides render HDL anti-inflammatory in mice and monkeys and reduce atherosclerosis in apoE null mice. Circ Res 97, 524-532.
11. Ni W, Tsuda Y, Sakono M, et al. (1998) Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. J Nutr 128, 1884-1889.
12. Sato M, Shibata K, Nomura R, et al. (2005) Linoleic acid-rich fats reduce atherosclerosis development beyond its oxidative and inflammatory stress-increasing effect in apolipoprotein E-deficient mice in comparison with saturated fatty acid-rich fats. Br J Nutr 94, 896-901.
13. Paigen B, Morrow A, Holmes PA, et al. (1987) Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68, 231-240.
14. Tangirala RK, Rubin EM & Palinski W (1998) Quantification of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL. J Lipid Res 36, 2320-2328.
15. Brown L, Rosner B, Willett WW, et al. (1999) Cholesterol-lowering effect of dietary fiber: a meta-analysis. Am J Clin Nutr 69, 30-42.
16. Auclair S, Silberberg M, Gueux E, et al. (2008) Apple polyphe-nols and fibers attenuate atherosclerosis in apolipoprotein E-deficient mice. J Agric Food Chem 56, 5558-5563.
17. Matchett MD, MacKinnon SL, Sweeney MI, et al. (2006) Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): possible roles for protein kinase C and mitogen-activated protein-kinase-mediated events. J Nutr Biochem 17, 117-125.
18. Oak HH, Bedoui JEI, Anglard P, et al. (2004) Red wine polyphenolic compounds strongly inhibit pro-matrix metallo-protease-2 expression and its activation in response to thrombin via direct inhibition of membrane type-1-matrix metalloproteinase in vascular smooth muscle cells. Circulation 110, 1861-1867.
19. Matsumoto M, Sata M, Fukuda D, et al. (2008) Orally administered eicosapentanoic acid reduces and stabilizes atherosclerotic lesions in apoE-deficient mice. Atherosclerosis 197, 524-533.
20. Nagarajan S, Burris RL, Stewart BW, et al. (2008) Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression. J Nutr 138, 332-337.
21. Cho SJ, Juillerat MA & Lee CH (2007) Cholesterol lowering mechanism of soybean protein hydrolysate. J Agric Food Chem 55, 10599-10604.
22. Nagaoka S, Futamura Y, Miwa K, et al. (2001) Identification of novel hypocjolesterolemic peptides derived from bovine milk b-lactoglobulin. Biochem Biophys Res Commun 281, 11-17.
23. 2 receptor. Peptides 24, 1955-1961.
24. Deng YM, Wu BJ, Witting PK, et al. (2004) Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation 110, 1855-1860.
25. Miguel M, Alvarez Y, Fandino RL, et al. (2007) Vasodilator effects of peptides derived from egg white proteins. Regulatory Peptides 140, 131-135.
26. 2\+ channels by Ro40-5967. Circ Res 75, 144-148.
27. Nakashima Y, Plump AS, Raines EW, et al. (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb Vasc Biol 14, 133-140.
28. Cabassi A, Vinci S, Cantoni AM, et al. (2002) Sympathetic activation in adipose tissue and skeletal muscle of hypertensive rats. Hypertension 39, 656-661.
29. Uguccioni M, Gionchetti P, Robbiani DF, et al. (1999) Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. Am J Pathol 155, 331-336.
30. Takeya M, Yoshimura T, Leonard EJ, et al. (1993) Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 24, 534-539.
31. Nakano K, Egashira K, Ohtani K, et al. (2008) Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice. Atherosclerosis 196, 172-179.